Japan’s Prescription Dispensing Costs Increase Six Percent
This article was originally published in PharmAsia News
Executive Summary
Japan's Central Social Insurance Council summarized July 16 electronic receipts of dispensing medical fees for fiscal year 2007.The average medical cost per prescription is ¥7,322, an increase of 5.8 percent compared to previous year. Among the two sections, cost of drugs increased by 7.5 percent to ¥5,387, compared to 1.2 percent increase in technical fees. The cost of drugs directly contributed to the medical cost increases, especially for cardiovascular treatments, which cost ¥1,360 per prescription, a 7.9 percent increase. Hypertension drugs increased 10.9 percent and followed by hyperlipidemia drugs, which increased 8.9 percent. (Click here for more - Japanese language) "Prescription Dispensing Cost Increase Nearly 6 Percent, Reported By Electronic Receipts" - Yakuji News (7/17/08)
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.